HRH1 and inflammatory bowel disease: Patients with IBD have been shown to benefit from the H1R antagonist loratadine, also known as ethyl 4-(8-chloro-5,6-dihydrobenzo[1,2]cyclohepta[2,4-b]pyridin-11-ylidene)piperidine-1-carboxylate) [81].